13FPulse
CL

CLDX CELLDEX THERAPEUTICS INC

2026Q2 · CUSIP 15117B202 · Sector: Healthcare & Biotech

Piling in

Net holder growth ranks near the top of the market

Funds that own it
249
Institutions that reported holding it to the SEC
Net increase in holders
+21
Last quarter 228 → now 249
How unusual is that
Top 20%
Stronger buying than 84% of US stocks
What the filings say, in one paragraph

249 funds held CLDX at the end of 2026Q2, up 21 from the quarter before. That is stronger buying than 83.9% of US stocks — among the most piled-into names this quarter. On the business itself, return on equity is -42.1%. CLDX has had 8 buying rushes in its history, and the price moved +33.9% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2019Q1: holders=52 2019Q2: holders=51 2019Q3: holders=53 2019Q4: holders=51 2020Q1: holders=45 2020Q2: holders=75 2020Q3: holders=92 2020Q4: holders=129 2021Q1: holders=117 2021Q2: holders=131 2021Q3: holders=160 2021Q4: holders=181 2022Q1: holders=168 2022Q2: holders=157 2022Q3: holders=160 2022Q4: holders=169 2023Q1: holders=161 2023Q2: holders=151 2023Q3: holders=143 2023Q4: holders=164 2024Q1: holders=197 2024Q2: holders=183 2024Q3: holders=176 2024Q4: holders=175 2025Q1: holders=171 2025Q2: holders=178 2025Q3: holders=183 2025Q4: holders=187 2026Q1: holders=228 2026Q2: holders=249 -51 -25.5 +0 +25.5 +51 40151262 19Q119Q420Q321Q222Q122Q423Q324Q225Q125Q426Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 8 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q2 Top 20%
2026Q1 Top 10%
2024Q1 Top 10% -7.1% -38.4%
2021Q3 Top 5% -31.0% -34.0%
2020Q4 Top 20% +1.3% +67.6%
2020Q3 Top 20% +44.1% +40.3%
2020Q2 Top 20% +82.5% +134.0%
2019Q1 Top 5%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
128
Change in large funds
+19
Total value they hold
$3.1B
Funds buying for the first time
49
Funds that sold out entirely
28
Price change that quarter
+30.6%
Funds holding puts (bearish)
10
Funds holding calls (bullish)
6

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
EPS (TTM)
$-4.36
EPS YoY
Revenue (TTM)
Revenue YoY
Net margin
ROE
-42.1%
Debt ratio
8.7%
FCF (TTM)
-$242M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS -0.45 2021-12-31: EPS -0.43 2022-03-31: EPS -0.49 2022-06-30: EPS -0.77 2022-09-30: EPS -0.57 2022-12-31: EPS -0.57 2023-03-31: EPS -0.62 2023-06-30: EPS -0.65 2023-09-30: EPS -0.81 2023-12-31: EPS -0.84 2024-03-31: EPS -0.56 2024-06-30: EPS -0.54 2024-09-30: EPS -0.64 2024-12-31: EPS -0.71 2025-03-31: EPS -0.81 2025-06-30: EPS -0.85 2025-09-30: EPS -1.01 2025-12-31: EPS -1.23 2026-03-31: EPS -1.18 2026-06-30: EPS -0.94 -1.35 -0.68 0.00 20212022202320242025202606/26 EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

Quarterly free cash flow
-67M-34M0K 20162017201820192020202120222023202420252026
Latest quarter $-67M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.